Bibliografia generale

1. Straub RH et al., Energy regulation and neuroendocrine-immune control in chronic inflammatory disease. J Intern Med, 2010,
267(6): 543-60
2. Straub RH, Evolutionary medicine and chronic inflammatory state-known and new concepts in pathophysiology. 2012, J MOL
MED (BERL) 90: 523-53
3. Tsigos C, Stefanaki C, Lambrou GI, Boschiero D, Chrousos GP, Stress and Inflammatory Biomarkers and Symptoms are Associated with Bio-Impedance Measures, Eur J Clin Invest. 2014 nov 28. doi: 10.1111/eci.12388.
4. Ippoliti F, Boschiero D, A Simple Non-Invasive Screening to Prevent Obesity through Body Composition Analysis (Bia-Acc)
J Obes Wt Loss Ther 2013, 3:169.
5. M Nater U; Fischer S; Ehlert U, Stress as a Pathophysiological Factor in Functional Somatic Syndromes, Current Psychiatry Reviews, Volume 7, Number 2, May 2011, pp. 152-169(18)
6. Ippoliti F1, Canitano N, Businaro R., Stress and obesity as risk factors in cardiovascular diseases: a neuroimmune perspective.
J Neuroimmune Pharmacol. 2013 Mar;8(1):212-26. doi: 10.1007/s11481-012-9432-6. Epub 2013 Jan 18.
7. Capuron L1, Poitou C, Machaux-Tholliez D, Frochot V, Bouillot JL, Basdevant A, Layé S, Clément K., Relationship between
adiposity, emotional status and eating behaviour in obese women: role of inflammation. Psychol Med. 2011 Jul;41(7):1517-28.
8. Kozlowska Kasia MBBS, PhD, Perspectives, Stress, Distress, and Bodytalk: Co-constructing Formulations with Patients Who
Presents with Somatic Symptoms, Harvard Review of Psychiatry: nov/dec 2013 – vol 21-Issue 6- p 314-333
9. Adam TC, Epel ES, Stress, eating and reward system, Physiol Behav 2007, 91: 449-458
10. Vachharajani V, Granger DN, Adipose tissue: a motor for the inflammation associated with obesity. 2009, IUBMB Life 61: 424-430
11. Kim JH, Bachmann RA, Chen J, Interleukin-6 and insulin resistance, 2009, Vitam Horm 80: 613-633
12. Huffman DM, Barzilai N, Role of visceral adipose tissue in aging. Biochim Biophys Acta, 2009, 1790: 1117-1123
13. Ellis KJ, Human body composition: in vivo methods. 2000, Physiol Rev, 80: 649-683
14. Heymsfield SB, Wang Z, Baumgartner RN, Ross R, Human body composition: advances in models and methods, 1997, Annu Rev
Nutr, 17: 527-558
15. Jaffrin My, Morel H, Body fluid volumes measurements by impedance: a review of bioimpedance spectroscopy (BIS) and
bioimpedance analysis (BIA) methods. Med Eng Phys 30: 1257-1269
16. Ruiz-Nunez B et al., Lifestyle and nutritional imbalances associated with western disease: causes and consequences of chronic
Systemic low grade inflammation in a evolutionary context. Journal on Nutritional Biochemistry 24, 2013, 1185-1201
17. Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med.
2006 Jun;119(6):526.e9-17.
18. Szulc P, Munoz F, Marchand F, Chapurlat R. Rapid loss of appendicular skeletal muscle mass is associated with higher all-cause
mortality in older men: the prospective MINOS study. Am J Clin Nutr. 2010 May;91(5):1227-36. Epub 2010 Mar 17.
19. Kyle UG, Genton L, Hans D, Karsegard L, Slosman DO, Pichard C. J. Age-related differences in fat-free mass, skeletal muscle,
body cell mass and fat mass between 18 and 94 years, Eur J Clin Nutr., 2001 Aug;55(8):663-72.
20. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt M, Harris TB. Relationship of interleukin-6 and
tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A
Biol Sci Med Sci. 2002 May;57(5):M326-32.
21. Toth MJ, Ades PA, Tischler MD, Tracy RP, LeWinter MM. Immune activation is associated with reduced skeletal muscle mass and
physical function in chronic heart failure. Int J Cardiol. 2006 May 10;109(2):179-87. Epub 2005 Jul 15.
22. David E. Brumbaugh,Tessa L. Crume,Kristen Nadeau,Ann Scherzinger and Dana Dabelea.Intramyocellular Lipid Is Associated with
Visceral Adiposity, Markers of Insulin Resistance, and Cardiovascular Risk in Prepubertal Children: The EPOCH Study.The Journal
of Clinical Endocrinology & Metabolism April 16, 2012.
23. Joerg C.W. Interer, William P.S. Steffee, W. Davy. Whole body protein turnover in aging man. Experimental Gerontology Vom 11,
Issue 3-4, 1976, Pg 79-87
24. Novak LP., Aging, total body potassium, fat-free mass, and cell mass in males and females between ages 18 and 85 years.
Gerontol. 1972 Oct;27(4):438-43.
25. S H Cohn, D Vartsky, S Yasumura, A Sawitsky, I Zanzi, A Vaswani, and K J Ellis. Compartmental body composition based
on total-body nitrogen, potassium, and calcium. The American Physiological Society
26. Sulli A, Montecucco CM, Caporali R, Cavagna L, Montagna P, Capellino S, Fazzuoli L, Seriolo B, Alessandro C,
Secchi ME, Cutolo M, Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia
rheumatica and elderly onset rheumatoid arthritis, Ann N Y Acad Sci. 2006 Jun;1069:307-14;
27. Sarzi-Puttini P, Atzeni F, Diana A, Doria A, Furlan R, Increased neural sympathetic activation in fibromyalgia
syndrome, Ann N Y Acad Sci. 2006 Jun;1069:109-17;
28. Geenen R, Van Middendorp H, Bijlsma JW, The impact of stressors on health status and hypothalamic-pituitary­
adrenal axis and autonomie nervous system responsiveness in rheumatoid arthritis, Ann N Y Acad Sci. 2006
29. Harbuz MS, Richards LJ, Chover-Gonzalez AJ, Marti-Sistac O, Jessop DS, Stress in autoimmune disease models,
Ann N Y Acad Sci. 2006 Jun;1069:51-61;
30. Demir H, Tanriverdi F, Ozogul N, Calis M, Kimap M, Ourak AC, Kelestimur F, Evaluation of the hypothalamic-pituitary­
adrenal axis in untreated patients with polymyalgia rheumatica and healthy controls, Scand J Rheumatol. 2006 May­
Jun;35(3):217 -23;
31. O’Kane M, Murphy EP, Kirby B, The role of corticotropin-releasing hormone in immune-mediated cutaneous
inflammatory disease, Exp Dermatol. 2006 Mar;15(3):143-53;
32. Hougee S, Faber J, Sanders A, Berg WB, Garssen J, Smit HF, Hoijer MA, Selective inhibition of COX-2 by a
standardized C02 extract of Humulus lupulus in vitro and its activity in a mouse model of zymosan-induced arthritis,
Pianta Med. 2006 Feb;72(3):228-33;
33. Gabay C, Interleukin-6 and chronic inflammation, Arthritis Res Ther. 2006;8 Suppl 2:S3. Epub 2006 Jul 28;
34. Hamminga EA, van der Lely AJ, Neumann HA, Thio HB, Chronic inflammation in psoriasis and obesity: implications for
therapy, Med Hypotheses. 2006;67(4):768-73. Epub 2006 Jun 15;
35. Richards HL, Ray DW, Kirby B, Mason D, Plant D, Main CJ, Fortune DG, Griffiths CE, Response of the hypothalamic­
pituitary-adrenal axis to psychological stress in patients with psoriasis, Br J Dennato!. 2005 Dee; 153(6): 1114-20;
36. Knoflach M, Kiechl S, Mayr A, Willeit J, Poewe W, Wick G, Allergie rhinitis, asthma, and atherosclerosis in the Bruneck and ARMY studies, Arch Intern Med. 2005 Nov 28;165(21):2521-6; .
37. Cutolo M, Villaggio B, Otsa K, Aakre O, Sulli A, Seriolo B, Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease’s symptoms, Autoimmun Rev. 2005 Nov;4(8):497-502. Epub 2005 Jun 13;
38. Wolters M, Diet and psoriasis: experimental data and clinical evidence, Br J Dermato!. 2005 Oct;153(4):706-14;
39. Lukaczer D, Darland G, Tripp M, Liska D, Lerman RH, Schiltz B, Bland JS, A pilot trial evaluating Meta050, a proprietary combination of reduced iso-alpha acids, rosemary extract and oleanolic acid in patients with arthritis and fibromyalgia, Phytother Res. 2005 Oct;19(10):864-9;
40. Eijsbouts AM, van den Hoogen FH, Laan RF, Hermus AR, Sweep CG, van de Putte LB, Hypothalamic-pituitary­
adrenal axis activity in patients with rheumatoid arthritis, Clin Exp Rheumatol. 2005 Sep-Oct;23(5):658-64;
41. Bos JD, de Rie MA, Teunissen MB, Piskin G, Psoriasis: dysregulation of innate immunity, Br J Dermatol. 2005
Jun; 152(6}: 1098-107;
42. Yahiro K, Shirasaka D, Tagashira M, Wada A, Morinaga N, Kuroda F, Choi O, Inoue M, Aoyama N, Ikeda M, Hirayama
T, Moss J, Noda M, Inhibitory effects of polyphenols on gastric injury by Helicobacter pylori VacA toxin, Helicobacter.
2005 Jun;10(3):231-9;
43. Messmer EM, Ocular allergies, Ophthalmologe. 2005 May;1 02(5):527-43;
44. Goronzy JJ, Weyand CM, Rheumatoid arthritis, Immunol Rev. 2005 Apr;204:55-73;
45. Denburg JA, Hatfield HM, Cyr MM, Hayes L, Holt PG, Sehmi R, Dunstan JA, Prescott SL, Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy, Pediatr Res. 2005 Feb;57(2):276-81;
46. Groneberg DA, Bester C, Grutzkau A, Serowka F, Fischer A, Henz BM, Welker P, Mast cells and vasculature in atopic dermatitis-potential stimulus of neoangiogenesis, Allergy. 2005 Jan;60(1 ):90-7;
47. McBeth J, Chiu YH, Silman AJ, Ray D, Morriss R, Oickens C, Gupta A, Macfarlane GJ, Hypothalamic-pituitary-adrenal
stress axis function and the relationship with chronic widespread pain and its antecedents; Arthritis Res Ther.
48. Mori TA, Beilin LJ, Omega-3 fatty acids and inflammation, Curr Atheroscler Rep. 2004 Nov;6(6):461-7;
49. Crofford LJ, Young EA, Engleberg NC, Korszun A, Brucksch CB, McClure LA, Brown MB, Demitrack MA, Basai circadian and pulsatile ACTH and corti sol secretion in patients with fibromyalgia and/or chronic fatigue syndrome,
Brain Behav Immun. 2004 Jul;18(4):314-25;
50. Barden AE, Mori TA, Dunstan JA, Taylor AL, Thornton CA, Croft KD, Beilin LJ, Prescott SL, Fish oll supplementation in pregnancy lowers F2-isoprostanes in neonates at high risk of atopy, Free Radic Res. 2004 Mar;38(3):233-9;
51. Raap U, Werfel T, Jaeger B, Schmid-Ott G, Atopic dermatitis and psychological stress, Hautarzt. 2003 Oct;54(10):925-
52. Buske-Kirschbaum A, von Auer K, Krieger S, Weis S, Rauh W, Hellhammer D, Blunted cortisol responses to psychosocial stress in asthmatic children: a generai feature of atopic disease?, Psychosom Med. 2003 Sep­ Oct;65(5):806-10;
53. Buske-Kirschbaum A, Hellhammer OH, Endocrine and immune responses to stress in chronic inflammatory skin disorders, Ann N Y Acad Sci. 2003 May;992:231-40;
54. Cutolo M, Sulli A, Pizzorni C, Craviotto C, Straub RH, Hypothalamic-pituitary-adrenocortical and gonadal functions in
rheumatoid arthritis, Ann N Y Acad Sci. 2003 May;992:107-17;
55. Ataoglu S, Ozcetin A, Yildiz O, Ataoglu A, Evaluation of dexamethasone suppression test in fibromyalgia patients with
orwithout depression, Swiss Med Wkly. 2003Apr 19;133(15-16):241-4;
56. Eichenfield LF, Hanifin JM, Beck LA, Lemanske RF Jr, Sampson HA, Weiss ST, Leung DY, Atopic dennatitis and
asthma: parallels in the evolution of treatment. Pediatrics. 2003 Mar; 111 (3):608-16;
57. Harle P, Cutolo M, Scholmerich J, Straub RH, Rheumatoid arthritis – pathogenetic role of neuroendocrine axes and the
peripheral nervous system, Med Klin (Munich). 2002 Dec 15;97(12):720-9;
58. Simopoulos AP, Omega-3 fatty acids in inflammation and autoimmune diseases, J Am Coli Nutr. 2002 Oec;21(6):495-
59. Gii A, Polyunsaturated fatty acids and inflammatory diseases, Biomed Pharmacother. 2002 Oct;56(8):388-96;
60. Tsigos C, Chrousos GP, Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress, J Psychosom Res.
61. Harbuz M, Neuroendocrine function and chronic inflammatory stress, Exp Physiol. 2002 Sep;87(5):519-25;
62. Bennett RM, Adult growth hormone deficiency in patients with fibromyalgia, Curr Rheumatol Rep. 2002 Aug;4(4):306-
63. Okifuji A, Turk DC, Stress and psychophysiological dysregulation in patients with fibromyalgia syndrome, Appl
Psychophysiol Biofeedback. 2002 Jun;27(2):129-41;
64. Mayser P, Mayer K, Mahloudjian M, Benzing S, Kramer HJ, Schill WB, Seeger W, Grimminger F, A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis, JPEN J
Parenter Enteral Nutr. 2002 May-Jun;26(3):151-8;
65. Geenen R, Jacobs JW, Bijlsma JW, Evaluation and management of endocrine dysfunction in fibromyalgia, Rheum Ois
Clin North Am. 2002 May;28(2):389-404;
66. Cutolo M, Straub RH, Foppiani L, Prete C, Pulsatelli L, Sulli A, Boiardi L, Macchioni P, Giusti M, Pizzomi C, Seriolo B, Salvarani C, Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6, J Rheumatol. 2002 Apr;29(4):748-56;
67. Mayser P, Grimm H, Grimminger F, n-3 fatty acids in psoriasis, Br J Nutr. 2002 Jan;87 Suppl1 :S77-82;
68. Cutolo M, Foppiani L, Minuto F, Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica, J Endocrinollnvest. 2002;25(10 Suppl):19-23;
69. Parker AJ, Wessely S, Cleare AJ, The neuroendocrinology of chronic fatigue syndrome and fibromyalgia, Psychol
Med. 2001 Nov;31(8):1331-45;

70. Morand EF, Leech M, Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis, Immunol
Celi Biol. 2001 Aug;79(4):395-9;
71. Furse RK, Rossetti RG, Zurier RB, Gammalinolenic acid, an unsaturated fatty acid with anti-inflammatory properties, blocks amplification of IL-1 beta production by human monocytes, J Immunol. 2001 Jul 1;167(1 ):490-6;
72. Oekkers JC, Geenen R, Godaert GL, Glaudemans KA, Lafeber FP, van Ooornen LJ, Bijlsma JW, Experimentally
challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis, Rheumatol. 2001 Jul;28(7):1496-504;
73. Neeck G, Crofford LJ, Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome, Rheum Ois Clin
North Am. 2000 Nov;26(4):989-1002;
74. Straub RH, Gluck T, Cutolo M, Georgi J, Helmke K, Scholmerich J, Vaith P, Lang B, The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica, Rheumatology (Oxford). 2000 Jun;39(6):624-31;
74. Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR, Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia, Arthritis Rheum. 2000 Apr;43(4):872-80;
75. Mastorakos G, llias I, Relationship between interleukin-6 (IL-6) and hypothalamic-pituitary-adrenal axis hormones in
rheumatoid arthritis, Z Rheumatol. 2000;59 SuppI2:lIfi5-9;
76. Eijsbouts AM, Murphy EP, The role of the hypothalamic-pituitary-adrenal axis in rheumatoid arthritis, Baillieres Best
Pract Res Ciin Rheumatol. 1999 Dec;13(4):599-613;
77. Winfield J8, Pain in fibromyalgia, Rheum Dis Clin North Am. 1999 Feb;25(1):55-79;
78. Oemir H, Kelestimur F, Tunc M, Kimap M, Ozugul Y, Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis, Scand J Rheumatol. 1999;28(1):41-6;
79. Buske-Kirschbaum A, Jobst S, Hellhammer OH, Altered reactivity of the hypothalamus-pituitary-adrenal axis in patients with atopic dermatitis: pathologic factor or symptom?, Ann N V Acad Sci. 1998 May 1;840:747-54;
80. Demitrack MA, Crofford LJ, Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome, Ann N Y Acad Sci. 1998 May 1;840:684-97;
81. Crofford lJ, The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome, Z Rheumatol. 1998;57 SuppI2:67-71;
82. Jongen-Lavrencic M, Peeters HR, Wognum A, Vreugdenhil G, Breedveld FC, Swaak AJ, Elevated levels of
intlammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease, J Rheumatol. 1997 Aug;24(8): 1504-9;
83. Buske-Kirschbaum A, Jobst S, Psych O, Wustmans A, Kirschbaum C, Rauh W, Hellhammer D, Attenuated free
cortisol response to psychosocial stress in children with atopic dermatitis, Psychosom Med. 1997 Jul-Aug;59(4):419-
84. Di Girolamo N, Visvanathan K, lloyd A, Wakefield D, Expression of TNF-alpha by human plasma cells in chronic
intlammation, J leukoc Biol. 1997 Jun;61 (6):667-78;
85. Calder PC, n-3 polyunsaturated fatty acids and cytokine production in health and disease, Ann Nutr Metab.
86. Crofford LJ, Engleberg NC, Demitrack MA, Neurohormonal perturbations in fibromyalgia, Baillieres Clin Rheumatol.
1996 May; 10(2):365-78;
87. Nishioka T, Kurokawa H, Takao T, Kumon V, Nishiya K, Hashimoto K, Differential changes of corticotropin releasing
hormone (CRH) concentrations in plasma and synovial fluids of patients with rheumatoid arthritis (RA), Endocr J. 1996
88. Biol Psychol. 2005 Feb;68(2):147-62.Cardiac Vagal Tone, defensiveness, and motivational style. Movius HL, Allen JJ.
89. Psychosom Med. 1994 May-Jun;56(3):181-6.Low vagal activity as mediating mechanism for the relationship between personality
factors and gastric symptoms in functional dyspepsia. Haug TT, Svebak S, Hausken T, Wilhelmsen I, Berstad A, Ursin H
90. Cardiol J. 2010;17(6):638-44.Vagus nerve stimulation: A new approach to reduce heart failure. Klein HU, Ferrari GM
91. Am J Cardiol. 1997 Aug 1;80(3):302-5.Differing effects of age on heart rate variability in men and women. Stein PK, Kleiger RE,
Rottman JN.
92. J Manipulative Physiol Ther. 2007 Jun;30(5):374-9.Effect of age and sex on heart rate variability in healthy subjects. Zhang J.
Pacing Clin Electrophysiol. 1996 Nov;19(11 Pt 2):1863-6.Changes in heart rate variability with age. Reardon M, Malik M.
93. Am J Cardiol. 2010 Apr 15;105(8):1181-5. Epub 2010 Feb 20.Relation of high heart rate variability to healthy longevity. Zulfiqar U,
Jurivich DA, Gao W, Singer DH.
94. Int J Geriatr Psychiatry. 2006 Feb;21(2):147-50.Differences in heart rate variability between depressed and non-depressed
elderly.van der Kooy KG, van Hout HP, van Marwijk HW, de Haan M, Stehouwer CD, Beekman AT.
95 Swiss Med Wkly. 2004 Sep 4;134(35-36):514-22. Heart rate variability: a noninvasive electrocardiographic method to measure the
autonomic nervous system. Sztajzel J.
96. Am Heart J. 1994 May;127(5):1376-81.Heart rate variability: a measure of cardiac autonomic tone. Stein PK, Bosner MS, Kleiger
RE, Conger BM.
97. Indian Pacing Electrophysiol J. 2003 Jan-Mar; 3(1): 34–40. Heart Rate Variability Analysis in General Medicine. Yi Gang, MD,
and Marek Malik, PhD, MD, FACC, FESC.
98. Am J Cardiol. 2013 May 16. Relation of Short-Term Heart Rate Variability to Incident Heart Failure (from the Multi-Ethnic Study of
Atherosclerosis). Shah SA, Kambur T, Chan C, Herrington DM, Liu K, Shah SJ.
99. Ann NY Acad Sci. 2006 Nov;1088:361-72. Beyond heart rate variability:vagal regulation of allostatic systems. Thayer JF,SternbergE
100. Swiss Med Wkly. 2004 Sep 4;134(35-36):514-22. Heart rate variability: a noninvasive electrocardiographic method to measure the
autonomic nervous system. Sztajzel J.
101. Psychoneuroendocrinology. 2008 Nov;33(10):1305-12. doi: 10.1016/j.psyneuen.2008.08.007. Epub 2008 Sep 25.The relationship
between heart rate variability and inflammatory markers in cardiovascular diseases. Haensel A, Mills PJ, Nelesen RA, Ziegler MG,
Dimsdale JE.
102. Clin Rheumatol. 2012 Sep;31(9):1377-81. doi: 10.1007/s10067-012-2015-3. Epub 2012 Jun 7.Decreased heart rate variability in
patients with psoriatic arthritis. Gaydukova I, Rebrov A, Nikitina N, Poddubnyy D.
103. Published online 2012 May 10. Heart Rate Variability Predicts Cell Death and Inflammatory Responses to Global Cerebral Ischemia.
Greg J. Norman, Kate Karelina, Gary G. Berntson, John S. Morris, Ning Zhang, and A. Courtney DeVries.
104. Psychosom Med. 2007 Nov;69(8):709-16. Epub 2007 Oct 17.Stimulated production of proinflammatory cytokines covaries inversely
with heart rate variability. Marsland AL, Gianaros PJ, Prather AA, Jennings JR, Neumann SA, Manuck SB.
105. Am Heart J. 2008 Oct;156(4):759.e1-7. doi: 10.1016/j.ahj.2008.07.009.Decreased heart rate variability is associated with higher
levels of inflammation in middle-aged men. Lampert R, Bremner JD, Su S, Miller A, Lee F, Cheema F, Goldberg J, Vaccarino V.
106. Int J Psychophysiol. 2012 Dec;86(3):269-75. doi: 10.1016/j.ijpsycho.2012.10.004. Epub 2012 Oct 13.The relationships among heart
rate variability, executive functions, and clinical variables in patients with panic disorder. Hovland A, Pallesen S, Hammar Å, Hansen
AL, Thayer JF, Tarvainen MP, Nordhus IH.
107. J Cardiovasc Dis Res. 2011 Apr;2(2):115-22. Heart rate variability study of childhood anxiety disorders. Sharma RK, Balhara YP,
Sagar R, Deepak KK, Mehta M.
108. Acta Paediatr. 2010 Apr;99(4):604-11. Epub 2010 Jan 28.Heart rate variability (HRV) in adolescent females with anxiety disorders
and major depressive disorder. Henje Blom E, Olsson EM, Serlachius E, Ericson M, Ingvar M.
110. Am Heart J. 2000 Oct;140(4 Suppl):77-83.Heart rate variability in depressive and anxiety disorders. Gorman JM, Sloan RP.
111. Aust N Z J Psychiatry. 2012 Oct;46(10):946-57. Epub 2012 Apr 23.Mind and heart: heart rate variability in major depressive disorder
and coronary heart disease a review and recommendations. Stapelberg NJ, Hamilton-Craig I, Neumann DL, Shum DH,
112. Basic Res Cardiol. 2013 May;108(3):345. Vagal stimulation triggers peripheral vascular protection through the cholinergic anti-
inflammatory pathway in a rat model of myocardial ischemia/reperfusion. Zhao M, He X, Bi XY, Yu XJ, Gil Wier W, Zang WJ.
113. Cleve Clin J Med. 2009 Apr;76 Suppl 2:S23-6. Vagal tone and the inflammatory reflex. Thayer JF.
114. BMC Complement Altern Med. 2012; 12(Suppl 1): P46. Assessment of autonomic tone at rest and during meditation in a longitudinal
study of an eight-week meditation intervention. G Desbordes, R Barbieri, L Citi, S Lazar, L Negi, C Raison, and E Schwartz
115. Medicine and Science in Sports and Exercise [2013]. High-Intensity Interval Exercise Improves Vagal Tone and Decreases
Arrhythmias in CHF. Guiraud T, Labrunee M, Gaucher-Cazalis K, Despas F, Meyer P, Bosquet L, Gales C, Vaccaro A, Bousquet M,
Galinier M, Sénard JM, Pathak A.
116. Shock. 2007 Nov;28(5):549-53.Depressed heart rate variability is associated with high IL-6 blood level and decline in the blood
pressure in septic patients. Tateishi Y, Oda S, Nakamura M, Watanabe K, Kuwaki T, Moriguchi T, Hirasawa H.
117. Kardiol Pol. 2005 Nov;63(5):478-85; discussion 486-7.Cytokines and heart rate variability in patients with chronic heart
failure.Straburzyńska-Migaj E, Ochotny R, Wachowiak-Baszyńska A, Straburzyńska-Lupa A, Leśniewska K, Wiktorowicz K,
Cieśliński A.
118. J Cardiol. 2013 Apr 20. pii: S0914-5087(13)00090-7. An inverse correlation between TNF alpha serum levels and heart rate
variability in patients with heart failure. Nikolic VN, Jevtovic-Stoimenov T, Stokanovic D, Milovanovic M, Velickovic-Radovanovic R,
Pesic S, Stoiljkovic M, Pesic G, Ilic S, Deljanin-Ilic M, Marinkovic D, Stefanovic N, Jankovic SM.
119. Brain Behav Immun. 2008 May;22(4):461-8. Epub 2007 Oct 30.Relationship between heart rate variability, interleukin-6, and soluble
tissue factor in healthy subjects. von Känel R, Nelesen RA, Mills PJ, Ziegler MG, Dimsdale JE.
120. A. Barbiero, Punti dolorosi. Neuroriflesoterapia personalizzata. Cleup Ed. Università di Padova. 2013
121. Manchikanti L, et al. An Update of Comprehensive Evidence-Based Guidelines for Interventional Techniques in Chronic
SpinalPain.Part II: Guidance and Recommendations.. 
Pain Physician 2013;16:S49-S283.
122. Van Buyten JP, et al. “The failed back surgery syndrome”: Definition and therapeutic 
algorithms — An update. European Journal
of Pain Supplements 2010;4:273–286.
123. Rossana Dezzoni, Anna Poggi, Manuela Soiat, Marino Viviani, Giorgio Berlot.
DAI-MPTIE (Dipartimento ad attività integrata di
Medicina Perioperatoria, Terapia Intensiva ed Emergenza) Ambul. di Terapia del Dolore, Osp. di Cattinara, Trieste. 
FBSS (failed back surgery syndrome): Controllo del dolore e miglioramento della qualità di vita con tecniche riflessoterapiche– Atti
XXVIII Congresso Nazionale S.I.R.A.A. Aosta, 4-5 ottobre 201
124. Nahler G, Metelmann H, Sperber H, Terapia della gonartrosi con Zeel versus acido ialuronico. Risultati di uno studio clinico
controllato randomizzato. Orthopadische Praxis, 1996, 5. (in italiano da La Medicina Biologica 1997/2; 11-16)
125. Weiser M, Strosser W, Klein P, Trattamento omeopatico delle sindromi vertiginose versus farmaci convenzionali. Risultati di uno
studio clinico in doppio cieco randomizzato. Archives of Otolaryngology – Head and neck Surgery (American Medical Association),
1998, August. (In italiano da La Medicina Biologica 1999/1: 43-44)
126. Maronna U, Weiser M, Klein P, Studio comparativo: Zeel versus Diclofenac. Orthopadische Praxis, 2000, 5. (in italiano da La
Medicina Biologica, 1999/4; 74. NdR l’abstract è stato pubblicato in italiano prima del testo in tedesco. E’ disponibile la traduzione
integrale in italiano non pubblicata)
127. Stam C, Bonnet M.S., Van Haselen RA, Effiicacia e sicurezza di un gel omeopatico nel trattamento del dolore lombare acuto:
sperimentazione multicentrica, randomizzata in doppio cieco. British Homeopathic Journal, 2001/90, 21-28
128. Wolschner U, Strosser W, Weiser M, Klein P, Terapia delle vertigini: Cocculus-Heel versus dimenidrinato. Risultati di uno studio
multicentrico controllato. Biologische Medizin, 2001, 4. (in italiano da La Medicina biologica, 2002/1; 15-20)
129. Haase R1, Piatkowski J, Ziemssen T. Long-term effects of Bio-Electromagnetic-Energy Regulation therapy on fatigue in patients
with multiple sclerosis. Altern Ther Health Med. 2011 Nov-Dec;17(6):22-8.
130. Piatkowski J1, Kern S, Ziemssen T. Effect of BEMER magnetic field therapy on the level of fatigue in patients with multiple sclerosis:
a randomized, double-blind controlled trial. J Altern Complement Med. 2009 May;15(5):507-11. doi: 10.1089/acm.2008.0501.
131. Mostert S1, Kesselring J. Effect of pulsed magnetic field therapy on the level of fatigue in patients with multiple sclerosis—a
randomized controlled trial. Mult Scler. 2005 Jun;11(3):302-5.
132. Walther M1, Mayer F, Kafka W, Schütze N. Effects of weak, low-frequency pulsed electromagnetic fields (BEMER type) on gene
expression of human mesenchymal stem cells and chondrocytes: an in vitro study. Electromagn Biol Med. 2007;26(3):179-90.
133. Tartaglia F., Estetica sanitaria, Editore Libreria, 1° edizione, settembre 2009.
134.Tsigos C, Stefanaki C, Lambrou GI, Boschiero D, Chrousos GP, Stress And Inflammatory Biomarkers And Symptom Are Associated With Bio-Impedance Measures, Eur J Clin Invest. 2014 Nov 28. Doi: 10.1111/eci.12388.
135. Gimeno D., Kivimäki M., Brunner E.J., Elovaini M. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study o Psycho Med vol 39, issue 3 march 2009, pp 413-423
136. MacfarlaneGl et all., Eular revised recommendations for the management of fibromyalgia, Ann Rheum Dis, 2016 jul 4. pii: annrehumdis-2016-209724. don: 10.1136/annrheumdis-2016-209724

responsabile web site: Dott. Paolo Bortolotto Medico Fisiatra - Padova

Registrant/Administration Carla Costabile C.F. CSTCRL61R50A166F Via Milano, 1 Selvazzano Dentro (Padova)

Copyright 2002 - 2014 Restyling and updating © 2024 Ultimo aggiornamento: 19 novembre 2017

privacy policy | cookie policy